| 1 | Severe acute interstitial lung disease after crizotini b therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. (23169500) | Tamiya A.... Nakagawa K. | 2013 | EML4 |
| 2 | Increased levels of interleukin-33 associated with bon e erosion and interstitial lung diseases in patients with rheumatoid arthritis. (22239947) | Xiangyang Z.... Jing L. | 2012 | IL33 |
| 3 | Increased serum COMP predicts mortality in SSc: result s from a longitudinal study of interstitial lung disease. (22253028) | Hesselstrand R.... Saxne T. | 2012 | COMP |
| 4 | Association of hepatocyte growth factor promoter poly morphism with severity of interstitial lung disease in Japanese patients with s ystemic sclerosis. (21520010) | Hoshino K.... Kuwana M. | 2011 | HGF |
| 5 | I^-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up. (21314931) | De Santis M.... Ferraccioli G. | 2011 | TMSB4X, TMSB10 |
| 6 | Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermat omyositis. (21052763) | Gono T.... Yamanaka H. | 2011 | IFIH1 |
| 7 | Serum TARC/CCL17 levels are increased in dermatomyosi tis associated with interstitial lung disease. (20800454) | Kawashima T.... Sato S. | 2010 | CCL17 |
| 8 | Antifibroblast antibodies from systemic sclerosis pat ients bind to {alpha}-enolase and are associated with interstitial lung disease . (19293162) | Terrier B.... Mouthon L. | 2010 | ENO1 |
| 9 | Interstitial lung disease in the course of the surfa ctant protein C deficiency coexisting with the primary humoral immunodeficiency - case study (20461694) | SzczawiA8ska-PopA8onyk A.... Langfort R. | 2010 | SFTPC |
| 10 | NKX2-1 mutations leading to surfactant protein promot er dysregulation cause interstitial lung disease in 'Brain-Lung-Thyroid Sy ndrome'. (20020530) | Guillot L.... Epaud R. | 2010 | NKX2-1 |
| 11 | Rapidly progressive fatal interstitial lung disease i n a patient with systemic sclerosis. (19337287) | Phillips K.... Seibold J.R. | 2009 | NPPB |
| 12 | Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. (19286849) | Hant F.N.... Silver R.M. | 2009 | MUC1, SFTPD |
| 13 | Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3. (19292764) | Armstrong L.... Millar A.B. | 2009 | TNF, ADAM17, PRTN3 |
| 14 | Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. (19117745) | Vasakova M.... Striz I. | 2009 | TGFB1, IL6, TNF |
| 15 | Bronchoalveoloar lavage fluid cytokines and chemokine s as markers and predictors for the outcome of interstitial lung disease in sys temic sclerosis patients. (19615053) | Schmidt K.... Riemekasten G. | 2009 | IL8, IL2, CCL2 |
| 16 | TH1/TH2 immune response in lung fibroblasts in interstitial lung disease. (18514095) | Sumida A.... Kawabe T. | 2008 | CXCR3, CCR4, CCL22 |
| 17 | The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance (18846962) | Ji Y.X.... Li J.L. | 2008 | TGFB1, MMP9 |
| 18 | Exacerbation of interstitial lung disease during etanercept therapy: Two cases. (17977770) | Tournadre A.... Soubrier M. | 2008 | TNF |
| 19 | Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. (18784990) | Bargagli E.... Rottoli P. | 2008 | S100A8, S100A9 |
| 20 | Relevance of pharmacogenetic aspects of mercaptopurine metabolism in the treatment of interstitial lung disease. (17940494) | Bakker J.A.... Bierau J. | 2007 | ITPA |
| 21 | Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases (18051824) | Kopinski P.... Szczeklik J. | 2007 | IFNG |
| 22 | Chitotriosidase activity in patients with interstitial lung diseases. (17631992) | Bargagli E.... Rottoli P. | 2007 | CHIT1 |
| 23 | Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. (17174272) | Mehrad B.... Strieter R.M. | 2007 | CXCL12 |
| 24 | Readministration of gefitinib in a responder after treatment discontinuation due to gefinitib-related interstitial lung disease: a case report. (18021415) | Takamochi K.... Funai K. | 2007 | EGFR |
| 25 | Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers. (16548909) | Kitajima H.... Abe S. | 2006 | SFTPD |
| 26 | Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease. (16837501) | Ye Q.... Guzman J. | 2006 | IL6, TNF, IL1B |
| 27 | Genetics of pediatric interstitial lung disease. (16721150) | Nogee L.M. | 2006 | SFTPC |
| 28 | Interstitial lung disease associated with gefitinib. (16137874) | Kataoka K.... Shimokata K. | 2006 | EGFR |
| 29 | Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. (15654008) | Al-Salmi Q.A.... Fan L.L. | 2005 | SFTPD |
| 30 | ABCA3 mutations associated with pediatric interstitial lung disease. (15976379) | Bullard J.E.... Nogee L.M. | 2005 | ABCA3, SFTPB |
| 31 | Interstitial lung disease in children -- genetic background and associated phenotypes. (15819986) | Hartl D.... Griese M. | 2005 | SFTPB |
| 32 | Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. (15293602) | Brasch F.... Beers M.F. | 2004 | SFTPC |
| 33 | BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. (15281432) | Meloni F.... Montecucco C. | 2004 | IL8, CCL2, IL18 |
| 34 | Interstitial lung disease (14563275) | Cuervo R.... Palau J.M. | 2003 | TGIF1 |
| 35 | Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. (11818324) | Ohnishi H.... Kohno N. | 2002 | CCL2, SFTPD |
| 36 | Genetic basis of familial interstitial lung disease: misfolding or function of surfactant protein C? (11991863) | Whitsett J.A. | 2002 | SFTPC |
| 37 | Surfactant protein deficiency in familial interstitial lung disease. (11445799) | Amin R.S.... Whitsett J.A. | 2001 | SFTPC, SFTPB |
| 38 | A mutation in the surfactant protein C gene associated with familial interstitial lung disease. (11207353) | Nogee L.M.... Whitsett J.A. | 2001 | SFTPC |
| 39 | Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases. (11733853) | Fireman E.... Grief J. | 2001 | PIK3C2A |
| 40 | Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease. (11153599) | Taniguchi H.... Kohno S. | 2000 | IL3, CSF2, IL5 |
| 41 | Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases. (10576621) | Shahar I.... Spirer Z. | 1999 | EDN1 |
| 42 | Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. (10398109) | Wallace W.A.... Howie S.E. | 1999 | IFNG |
| 43 | Anti-KS: identification of autoantibodies to asparagi nyl-transfer RNA synthetase associated with interstitial lung disease. (9973509) | Hirakata M.... Targoff I.N. | 1999 | NARS |
| 44 | CYFRA 21-1, a cytokeratin subunit 19 fragment, in bronchoalveolar lavage fluid from patients with interstitial lung disease. (9682677) | Kanazawa H.... Yoshikawa J. | 1998 | KRT19 |
| 45 | Protein C anticoagulant system in patients with interstitial lung disease. (9620917) | Kobayashi H.... Adachi Y. | 1998 | PROC |
| 46 | Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. (8616567) | Agostini C.... Semenzato G. | 1996 | TNFRSF1B, CD27, TNFSF8 |
| 47 | Intercellular interactions in morphogenesis of initial lesions and sclerosis in interstitial lung diseases (7626980) | Kogan E.A.... Ovchinnikov A.A. | 1995 | FOS, TNF |
| 48 | Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. (8200639) | Iyonaga K.... Takahashi K. | 1994 | CCL2 |
| 49 | Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. (8370444) | Fireman E.... Greif J. | 1993 | IL2RA, IL2, IL2RB |
| 50 | In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. (1572093) | Prior C.... Haslam P.L. | 1992 | IFNG |
